Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-059558

CEO and Chairman sold 50,040 shares at an average $46.99 ($2,351,429)

  • CEO and Chairman acquired 50,040 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS CHAD M CEO and Chairman 2020-11-17 Option exercise +16,680 $0.33 $5,504 1,794,860 D
ROBINS CHAD M CEO and Chairman 2020-11-17 Sale −11,047 $45.84 $506,394 1,783,813 D
ROBINS CHAD M CEO and Chairman 2020-11-17 Sale −5,633 $46.68 $262,948 1,778,180 D
ROBINS CHAD M CEO and Chairman 2020-11-18 Option exercise +16,680 $0.33 $5,504 1,794,860 D
ROBINS CHAD M CEO and Chairman 2020-11-18 Sale −1,200 $46.68 $56,016 1,793,660 D
ROBINS CHAD M CEO and Chairman 2020-11-18 Sale −2,000 $47.64 $95,280 1,791,660 D
ROBINS CHAD M CEO and Chairman 2020-11-18 Sale −13,480 $48.52 $654,050 1,778,180 D
ROBINS CHAD M CEO and Chairman 2020-11-19 Option exercise +16,680 $0.33 $5,504 1,794,860 D
ROBINS CHAD M CEO and Chairman 2020-11-19 Sale −7,647 $45.60 $348,703 1,787,213 D
ROBINS CHAD M CEO and Chairman 2020-11-19 Sale −3,773 $46.69 $176,161 1,783,440 D
ROBINS CHAD M CEO and Chairman 2020-11-19 Sale −4,360 $47.75 $208,190 1,779,080 D
ROBINS CHAD M CEO and Chairman 2020-11-19 Sale −900 $48.54 $43,686 1,778,180 D
Derivatives
ROBINS CHAD M CEO and Chairman 2020-11-17 Option exercise · Stock Option (Right to Buy) −16,680 82,920 D
ROBINS CHAD M CEO and Chairman 2020-11-18 Option exercise · Stock Option (Right to Buy) −16,680 66,240 D
ROBINS CHAD M CEO and Chairman 2020-11-19 Option exercise · Stock Option (Right to Buy) −16,680 49,560 D
Open-market sales · 50,040 sh · avg $46.99 · $2,351,429
Loading xslF345X03/doc4.xml…